MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF

B Li1,2,3, W W Xu1,2, L Han1,2

  • 1School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, China.

Oncogene
|March 14, 2017
PubMed

Insights

MicroRNA-377 (miR-377) is downregulated in esophageal squamous cell carcinoma (ESCC). Restoring miR-377 inhibits ESCC growth and metastasis, suggesting its potential as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Esophageal cancer, particularly ESCC, has poor survival rates and limited treatment options.
  • MicroRNAs (miRNAs) are emerging as critical regulators in cancer development.
  • The role of miR-377 in ESCC remains largely unexplored despite its location on a frequently deleted chromosome region.

Purpose of the Study:

  • To investigate the biological functions, clinical significance, and therapeutic potential of miR-377 in esophageal squamous cell carcinoma (ESCC).
  • To determine the correlation between miR-377 expression levels and patient survival, tumor stage, metastasis, and treatment response.
  • To elucidate the molecular mechanisms by which miR-377 affects ESCC initiation and progression.

Main Methods:

  • Quantitative analysis of miR-377 expression in ESCC tumor tissues and patient serum.
  • Correlation analysis between miR-377 levels and clinical parameters (survival, tumor stage, metastasis, treatment resistance).
  • In vitro and in vivo experiments to assess the effects of miR-377 overexpression and silencing on ESCC cell behavior and tumor growth.
  • Mechanistic studies involving direct binding analysis of miR-377 to target genes (CD133, VEGF).
  • Evaluation of systemic delivery of miR-377 mimics in a mouse model.

Main Results:

  • miR-377 expression was significantly downregulated in ESCC tumor tissues and serum.
  • Lower miR-377 levels correlated with poorer patient survival, advanced tumor stage, metastasis, and chemoradiotherapy resistance.
  • Overexpression of miR-377 inhibited ESCC initiation, growth, angiogenesis, and metastasis in vitro and in vivo.
  • miR-377 directly targets and regulates CD133 and VEGF.
  • Systemic delivery of miR-377 mimic suppressed tumor growth, angiogenesis, and lung metastasis in mice without significant toxicity.

Conclusions:

  • miR-377 functions as a tumor suppressor in ESCC by inhibiting initiation, progression, and metastasis.
  • miR-377 holds promise as a non-invasive diagnostic and prognostic biomarker for ESCC.
  • Restoring miR-377 levels represents a potential therapeutic strategy for ESCC patients.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K